EUVIMEDOpdag EUVIMED
Crossref

FAM162A Promotes Osteosarcoma Progression Via Activating HIF‐1α to Enhance Glycolysis

Jun Zhang iD, Zhigang Liu, Li Fan, Rubo Cao, Zhuang Miao, Chenxin Guo, Ningning Yu, Haotian Yu, Xiaoqian Dang

Molecular Carcinogenesis · 2026-06 · 65 (6) · 715-727

DOI: 10.1002/mc.70112 ↗

At a glance

Journal article in Molecular Carcinogenesis, published online on 2026-03-26. Written by Jun Zhang and 8 co-authors. Institution: Department of Orthopaedics, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China. Major MEDLINE topics: Hypoxia-Inducible Factor 1, alpha Subunit, Osteosarcoma, Glycolysis, Bone Neoplasms. 32 references. Funded by: Key research and development plan of Shaanxi Province.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Osteosarcoma (OS) [1] is the most prevalent primary bone cancer and is highly prone to both local invasion and metastasis. FAM162A, a protein implicated in cell growth transformation, is recognized as an oncogene in various cancers. Its role in osteosarcoma, however, remains poorly understood. This study investigates the role of FAM162A in the OS development. We identified that FAM162A was observably upregulated in osteosarcoma and inversely correlated with the prognosis of patients using bioinformatics and immunohistochemical analysis. The CCK‐8, colony formation, scratch, and trans‐well migration assays were performed to detect the effects of FAM162A on OS cell proliferation and migration. Then we found FAM162A‐associated pathways in OS using GO and KEGG analyses and verified and used the downstream factor HIF‐1α inhibitor to restore the OS cell proliferation induced by FAM162A overexpression to detect the mechanism of FAM162A in OS. Mechanistically, FAM162A facilitates glycolysis by activating HIF‐1α and subsequently PKM2, a critical glycolytic gene, thereby advancing OS progression. These insights elucidated FAM162A's involvement in OS and its impact on glucose metabolism reprogramming, underscoring its potential as a therapeutic target.

Subjects

MeSH terms (MEDLINE)

Hypoxia-Inducible Factor 1, alpha SubunitOsteosarcomaGlycolysisBone NeoplasmsHumansCell ProliferationGene Expression Regulation, NeoplasticCell Line, TumorDisease ProgressionCell MovementAnimalsPrognosisMembrane Proteins

Author keywords

FAM162AHIF1αglycolysisosteosarcoma

Substances

Hypoxia-Inducible Factor 1, alpha SubunitHIF1A protein, humanMembrane Proteins

Authors and institutions

  • Department of Orthopaedics, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
  • Emergency Surgery Department, Sinopharm Dongfeng General Hospital, Hubei University of Medicine, Shiyan, Hubei, China.
  • Emergency Surgery Department, Taikang Clinical College of Wuhan University, Taikang Tongji Wuhan Hospital, Wuhan, Hubei, China.
  • Department of Pain and Rehabilitation, Wuhan Clinical Research Center for Acupotomy Medicine, Wuhan Third Hospital, Wuhan, Hubei, China.
  • Department of Medicine, School of Medicine, Wuhan University of Science and Technology, Wuhan, Hubei, China.
  • Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

ORCID profiles: Jun Zhang

Funding

  • Key research and development plan of Shaanxi Province

Cite

APA

Zhang, J., Liu, Z., Fan, L., Cao, R., Miao, Z., Guo, C., Yu, N., Yu, H., & Dang, X. (2026). FAM162A Promotes Osteosarcoma Progression Via Activating HIF‐1α to Enhance Glycolysis. Molecular Carcinogenesis, 65(6), 715-727. https://doi.org/10.1002/mc.70112

Vancouver

Zhang J, Liu Z, Fan L, Cao R, Miao Z, Guo C, et al. FAM162A Promotes Osteosarcoma Progression Via Activating HIF‐1α to Enhance Glycolysis. Molecular Carcinogenesis. 2026;65(6):715-727. doi:10.1002/mc.70112

BibTeX
@article{Zhang2026,
  author = {Zhang, Jun and Liu, Zhigang and Fan, Li and Cao, Rubo and Miao, Zhuang and Guo, Chenxin and Yu, Ningning and Yu, Haotian and Dang, Xiaoqian},
  title = {FAM162A Promotes Osteosarcoma Progression Via Activating HIF‐1α to Enhance Glycolysis},
  journal = {Molecular Carcinogenesis},
  year = {2026},
  volume = {65},
  number = {6},
  pages = {715--727},
  doi = {10.1002/mc.70112}
}
Start for free →